|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gastroenterologist perceptions of faecal microbiota transplantation显示文摘AIM: To explore gastroenterologist perceptions towards and experience with faecal microbiota transplantation(FMT).METHODS: A questionnaire survey consisting of 17 questions was created to assess gastroenterologists' attitude towards and experience with FMT. This was anonymously distributed in hard copy format amongst attendees at gastroenterology meetings in Australia between October 2013 and April 2014. Basic descriptive statistical analyses were performed.RESULTS: Fifty-two clinicians participated. Twenty one percent had previously referred patients for FMT,8% more than once. Ninety percent would refer patients with Clostridium difficile infection(CDI) for FMT if easily available,37% for ulcerative colitis,13% for Crohn's disease and 6% for irritable bowel syndrome. Six percent would not refer any indication,including recurrent CDI. Eighty-six percent would enroll patients in FMT clinical trials. Thirty-seven percent considered the optimal mode of FMT administration transcolonoscopic,17% nasoduodenal,13% enema and 8% oral capsule. The greatest concerns regarding FMT were: 42% lack of evidence,12% infection risk,10% non infectious adverse effects/lack of safety data,10% aesthetic,10% lack of efficacy,4% disease exacerbation,and 2% inappropriate use; 6% had no concerns. Seventy seven percent believed there is a lack of accessibility while 52% had an interest in learning how to provide FMT. Only 6% offered FMT at their institution.CONCLUSION: Despite general enthusiasm,most gastroenterologists have limited experience with,or access to,FMT. The greatest concerns were lack of supportive evidence and safety issues. However a significant proportion would refer indications other than CDI for FMT despite insufficient evidence. These data provide guidance on where education and training are required. | Sudarshan Paramsothy Alissa J Walsh Thomas Borody Douglas Samuel Johan van den Bogaerde Rupert WL Leong Susan Connor Watson Ng Hazel M Mitchell Nadeem O Kaakoush Michael A Kamm | 2015 | World Journal of Gastroenterology2015，21，38： | 5 |
| 2 | Treating Clostridium difficile Infection With Fecal Microbiota Transplantation显示文摘 | Johan S. Bakken Thomas Borody Lawrence J. Brandt Joel V. Brill Daniel C. Demarco Marc Alaric Franzos Colleen Kelly Alexander Khoruts Thomas Louie Lawrence P. Martinelli Thomas A. Moore George Russell Christina Surawicz | 2011 | Clinical Gastroenterology and Hepatology2011，，12： | 5 |
| 3 | Fecal Microbiota Transplantation显示文摘 | Thomas Julius Borody Jordana Campbell | 2012 | Gastroenterology Clinics of North America2012，，4： | 3 |
| 4 | Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions显示文摘 | Thomas J. Borody Sudarshan Paramsothy Gaurav Agrawal | 2013 | Current Gastroenterology Reports2013，，8： | 3 |
| 5 | Therapeutic Potential of Fecal Microbiota Transplantation显示文摘 | Loek P. Smits Kristien E.C. Bouter Willem M. de Vos Thomas J. Borody Max Nieuwdorp | 2013 | Gastroenterology2013，，5： | 2 |
| 6 | Fecal mi- crobiota transplantation : indications, methods, evidence, and future directions 显示文摘 | Borody T J Paramsothy S Agrawal G | 2013 | Curr Gastro- enterol Rep2013，15，8： | 1 |
| 7 | Therapeutic faecal microbiota transplantation: current status and future developments显示文摘 | Thomas J. Borody Lawrence J. Brandt Sudarshan Paramsothy | 2014 | Current Opinion in Gastroenterology2014，，1： | 1 |
| 8 | Treatment of ulcerative colitis using fecal bacteriotherapy显示文摘 | Borody TJ Warren EF Leis S | 2003 | J Clin Gastroenterol2003，37，1： | 1 |
| 9 | Efficacy and safety of rifabutincontaining'rescue therapy'for resistant Helicobacter pylori infection显示文摘 | Borody TJ Pang G Wettstein AR | 2006 | Aliment Pharmacol Ther2006，23，4： | 1 |
| 10 | Fecal microbiota transplantation in ulcerative colitis: review of 24 years experience显示文摘 | Borody T Wettstein A Campbell J | 2012 | Am J Gastroenterol2012，107，1： | 1 |
| 11 | Fecal microbiota transplantation: techniques, applications, and issues 显示文摘 | Borody TJ Campbell J | 2012 | Gastroenterol Clin North Am2012，41，4： | 1 |
| 12 | Treating Clostridium difficile Infection With Fecal Microbiota Transplantation显示文摘 | Johan S. Bakken Thomas Borody Lawrence J. Brandt Joel V. Brill Daniel C. Demarco Marc Alaric Franzos Colleen Kelly Alexander Khoruts Thomas Louie Lawrence P. Martinelli Thomas A. Moore George Russell Christina Surawicz | 2011 | Clinical Gastroenterology and Hepatology2011，，12： | 1 |
| 13 | Bowel-flora alteration : a potential cure for inflammatory bowel disease and irritable bowel syndrome显示文摘 | Borody TJ George L Andrews P | 1989 | Med J Aust1989，150，10： | 1 |
| 14 | Treating Clostridi- um difficile infection with fecal microbiota transplantation 显示文摘 | Bakken J S Borody T Brandt L J | 2011 | Clin Gastroenterol Hepatol2011，9，12： | 1 |
| 15 | Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy显示文摘 | Thomas J. Borody Eloise F. Warren Sharyn Leis Rosa Surace Ori Ashman | 2003 | Journal of Clinical Gastroenterology2003，，1： | 1 |
| 16 | Fecal microbiota transplantation and emerging applications 显示文摘 | Borody TJ Khoruts A | 2012 | Nat Rev Gastroenterol Hepatol2012，9，2： | 1 |
| 17 | Rpaid dissolution of gallstones by methyhert-butyl ether Preliminary observations显示文摘 | Allen M J Borody TJ Bugliosi TF | 2011 | N Engl J Med2011，，312： | 1 |
| 18 | Durable alteration of the colonic microbiota by the administration of donor fecal flora显示文摘 | Grehan MJ Borody TJ Leis SM | 2010 | J Clin Gastroenterol2010，44，8： | 1 |
| 19 | Fecal microbiota transplantation (FMT) in multiple sclerosis (MS) 显示文摘 | Borody TJ Leis SM Campbell JL | 2011 | Am J Gastroenterol2011，106，： | 1 |
| 20 | Fecal microbiota transplantation and emerging applications 显示文摘 | Borody T J Khornts A | 2012 | Nat Rev Gastroenterol ttepatol2012，9，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员